Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer

被引:679
|
作者
Dong, Chenfang [1 ,5 ]
Yuan, Tingting [1 ,5 ]
Wu, Yadi [2 ,5 ]
Wang, Yifan [1 ,5 ]
Fan, Teresa W. M. [6 ,7 ]
Miriyala, Sumitra [4 ,5 ]
Lin, Yiwei [1 ,5 ]
Yao, Jun [8 ]
Shi, Jian [1 ,5 ]
Kang, Tiebang [10 ]
Lorkiewicz, Pawel [6 ,7 ]
St Clair, Daret [4 ,5 ]
Hung, Mien-Chie [9 ,11 ,12 ]
Evers, B. Mark [1 ,3 ,5 ]
Zhou, Binhua P. [1 ,5 ]
机构
[1] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA
[2] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40506 USA
[3] Univ Kentucky, Coll Med, Dept Surg, Lexington, KY 40506 USA
[4] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40506 USA
[5] Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA
[6] Univ Louisville, Dept Chem, Ctr Regulatory & Environm Analyt Metabol, Louisville, KY 40202 USA
[7] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
[9] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[10] State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[11] China Med Univ, Ctr Mol Med, Taichung, Taiwan
[12] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan
基金
美国国家科学基金会;
关键词
ISOTOPE-RESOLVED METABOLOMICS; OXIDATIVE STRESS; BETA-CATENIN; LUNG-CANCER; PYRUVATE-KINASE; CELL; PROLIFERATION; TRANSITIONS; GLYCOLYSIS; SURVIVAL;
D O I
10.1016/j.ccr.2013.01.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The epithelial-mesenchymal transition (EMT) enhances cancer invasiveness and confers tumor cells with cancer stem cell (CSC)-like characteristics. We show that the Snail-G9a-Dnmt1 complex, which is critical for E-cadherin promoter silencing, is also required for the promoter methylation of fructose-1,6-biphosphatase (FBP1) in basal-like breast cancer (BLBC). Loss of FBP1 induces glycolysis and results in increased glucose uptake, macromolecule biosynthesis, formation of tetrameric PKM2, and maintenance of ATP production under hypoxia. Loss of FBP1 also inhibits oxygen consumption and reactive oxygen species production by suppressing mitochondrial complex 1 activity; this metabolic reprogramming results in an increased CSC-like property and tumorigenicity by enhancing the interaction of beta-catenin with T-cell factor. Our study indicates that the loss of FBP1 is a critical oncogenic event in EMT and BLBC.
引用
收藏
页码:316 / 331
页数:16
相关论文
共 50 条
  • [31] BRCA1 Pathway Function in Basal-Like Breast Cancer Cells
    Hill, Sarah J.
    Clark, Allison P.
    Silver, Daniel P.
    Livingston, David M.
    MOLECULAR AND CELLULAR BIOLOGY, 2014, 34 (20) : 3828 - 3842
  • [32] LSD1 is associated with poor prognosis in basal-like breast cancer
    Nagasawa, S.
    Tsugawa, K.
    BREAST, 2015, 24 : S102 - S103
  • [33] Claudin 1 expression in basal-like breast cancer is related to patient age
    Anne A Blanchard
    Xiuli Ma
    Kevin J Dueck
    Carla Penner
    Steven C Cooper
    Drew Mulhall
    Leigh C Murphy
    Etienne Leygue
    Yvonne Myal
    BMC Cancer, 13
  • [34] Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
    Moestue, Siver A.
    Dam, Cornelia G.
    Gorad, Saurabh S.
    Kristian, Alexandr
    Bofin, Anna
    Maelandsmo, Gunhild M.
    Engebraten, Olav
    Gribbestad, Ingrid S.
    Bjorkoy, Geir
    BREAST CANCER RESEARCH, 2013, 15 (01):
  • [35] The role of caspase-1 in basal-like breast cancer and the tumor microenvironment
    Marini, Wanda
    Zheng, Weiyue
    Murakami, Kiichi
    Ohashi, Pamela S.
    Reedijk, Michael
    CANCER RESEARCH, 2023, 83 (07)
  • [36] ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer
    Pandey, Gaurav
    Borcherding, Nicholas
    Kolb, Ryan
    Kluz, Paige
    Li, Wei
    Sugg, Sonia
    Zhang, Jun
    Lai, Dazhi A.
    Zhang, Weizhou
    CANCERS, 2019, 11 (05)
  • [37] Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer
    Mott, Landon
    Su, Kai
    Pack, Daniel W.
    CANCER GENE THERAPY, 2018, 25 (3-4) : 84 - 91
  • [38] Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer
    Suhaib K. Abdeen
    Uri Ben-David
    Aya Shweiki
    Bella Maly
    Rami I. Aqeilan
    Cell Death & Disease, 9
  • [39] Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer
    Landon Mott
    Kai Su
    Daniel W. Pack
    Cancer Gene Therapy, 2018, 25 : 84 - 91
  • [40] Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
    Siver A Moestue
    Cornelia G Dam
    Saurabh S Gorad
    Alexandr Kristian
    Anna Bofin
    Gunhild M Mælandsmo
    Olav Engebråten
    Ingrid S Gribbestad
    Geir Bjørkøy
    Breast Cancer Research, 15